Independent clinic-based evaluation of dual POCTs for screening for HIV and syphilis in men who have sex with men in Italy, Malta, Peru, and the United Kingdom

Nigel Sherriff,Massimo Mirandola,Ronaldo Silva,Maddalena Cordioli,Alexandra Sawyer,Lorenzo Gios,Antonella Zorzi,Jorg Huber,Jaime Vera,Daniel Richardson,Mohammed Hassan-Ibrahim,Dominika Wlazly,Valeska Padovese,Christopher Barbara,Anabel Darmanin,Aaron Schembri,Carlos Caceres,Silver Vargas,Karel Blondeel,James Kiarie,Firdavs Kurbonov,Rosanna W. Peeling,Soe Soe Thwin,Igor Toskin
DOI: https://doi.org/10.1186/s12879-024-09019-3
IF: 3.7
2024-03-02
BMC Infectious Diseases
Abstract:Globally, the incidence of HIV and syphilis can be reduced by the use of validated point of care tests (POCTs). As part of the WHO PRoSPeRo Network, we aimed to evaluate the performance, acceptability, and operational characteristics of two dual HIV/syphilis POCTs (Bioline HIV/Syphilis Duo (Abbott) and DPP® HIV-Syphilis assay (Chembio) for the screening of HIV and syphilis amongst men who have sex with men (MSM).
infectious diseases
What problem does this paper attempt to address?